Justin Walsh
Stock Analyst at Jones Trading
(3.13)
# 1,116
Out of 5,127 analysts
38
Total ratings
38.89%
Success rate
17.95%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $16 | $3.85 | +315.58% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $320.48 | -74.10% | 1 | Sep 18, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $109 → $84 | $67.11 | +25.17% | 10 | Sep 16, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.25 | +1,124.49% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $3.05 | +293.44% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $4.42 | +578.73% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $57.28 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $2.10 | +423.81% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $16.65 | +8.11% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $28.25 | +48.67% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $4.74 | +364.14% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.55 | +251.65% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.36 | +358.72% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.67 | +497.01% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.42 | +484.80% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $13.89 | +2,491.79% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $0.88 | +49,900.00% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.26 | +28,406.27% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $47.71 | -58.08% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.00 | +19,900.00% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $6.60 | +51.52% | 1 | Jan 19, 2022 |
AtaiBeckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $3.85
Upside: +315.58%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $320.48
Upside: -74.10%
Lantheus Holdings
Sep 16, 2025
Maintains: Buy
Price Target: $109 → $84
Current: $67.11
Upside: +25.17%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.25
Upside: +1,124.49%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $3.05
Upside: +293.44%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $4.42
Upside: +578.73%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $57.28
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $2.10
Upside: +423.81%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $16.65
Upside: +8.11%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $28.25
Upside: +48.67%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $4.74
Upside: +364.14%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $4.55
Upside: +251.65%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.36
Upside: +358.72%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.67
Upside: +497.01%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $3.42
Upside: +484.80%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $13.89
Upside: +2,491.79%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $0.88
Upside: +49,900.00%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.26
Upside: +28,406.27%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $47.71
Upside: -58.08%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.00
Upside: +19,900.00%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $6.60
Upside: +51.52%